Accuracy of Commercially Available Heart Rate Monitors II
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02818244 |
Recruitment Status :
Completed
First Posted : June 29, 2016
Results First Posted : July 2, 2017
Last Update Posted : July 2, 2017
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Healthy | Device: Fit Bit Blaze Heart Rate Monitoring Device Device: Garmin Forerunner 235 Heart Rate Monitoring Device Device: Tom Tom Spark Cardio Heart Rate Monitoring Device Device: Apple Watch Heart Rate Monitoring Device Device: Scosche Rhythm + Heart Rate Monitor | Not Applicable |
In a previous trial, investigators compared the accuracy of four devices (Apple Watch, Fitbit Charge HR, Mio Fuse, Basis Peak) worn by subjects while performing a graded exercise program on a treadmill. Investigators discovered that the Apple Watch and Mio Fuse had a correlation coefficient (rc) of .91, Fitbit Charge HR had an rc of .84, and Basis Peak had an rc of .83. That study has been submitted for publication.
Reviewers of the first study raised an important question: how do commercial optical heart rate monitors perform when measuring heart rate during other popular forms of exercise? This study addresses that question.
Objective:
The objective of this study is to evaluate the accuracy of four heart rate monitors when used during three different exercises: treadmill, stationary bicycle, elliptical trainer.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 50 participants |
Allocation: | Non-Randomized |
Intervention Model: | Factorial Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Screening |
Official Title: | Accuracy of Commercially Available Heart Rate Monitors II |
Study Start Date : | June 2016 |
Actual Primary Completion Date : | October 2016 |
Actual Study Completion Date : | October 2016 |
Arm | Intervention/treatment |
---|---|
Active Comparator: Fit Bit Blaze
Fit Bit Blaze Heart Rate Monitoring Device
|
Device: Fit Bit Blaze Heart Rate Monitoring Device |
Active Comparator: Garmin Forerunner 235
Garmin Forerunner 235 Heart Rate Monitoring Device
|
Device: Garmin Forerunner 235 Heart Rate Monitoring Device |
Active Comparator: Tom Tom Spark Cardio
Tom Tom Spark Cardio Heart Rate Monitoring Device
|
Device: Tom Tom Spark Cardio Heart Rate Monitoring Device |
Active Comparator: Apple Watch
Apple Watch Heart Rate Monitoring Device
|
Device: Apple Watch Heart Rate Monitoring Device |
Active Comparator: Scosche Rhythm +
Scosche Rhythm + Heart Rate Monitoring Device
|
Device: Scosche Rhythm + Heart Rate Monitor |
- Primary Outcome Measure: Heart Rate Monitor Accuracy Compared to ECG Expressed as Correlation Coefficient. [ Time Frame: 24 minutes ]The primary outcome measure is the accuracy of each heart rate monitor compared to ECG. This will be expressed by the correlation coefficient and will also be depicted by Bland-Altman plots.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Age > 18 years
- Able and willing to exercise for a total of fifteen minutes
Exclusion Criteria:
- Health issues that preclude or contraindicate walking and/or jogging, including cardiovascular, orthopedic, pulmonary and other conditions
- Presence of a cardiac pacemaker
- Known cardiovascular disease
- Known heart rhythm disorders
- Use of Beta-blockers or antiarrhythmic medications
- Tattoos around the wrist or forearm area

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02818244
Principal Investigator: | Marc Gillinov, MD | The Cleveland Clinic |
Responsible Party: | Marc Gillinov, MD, Principal Investigator, The Cleveland Clinic |
ClinicalTrials.gov Identifier: | NCT02818244 |
Other Study ID Numbers: |
16-743 |
First Posted: | June 29, 2016 Key Record Dates |
Results First Posted: | July 2, 2017 |
Last Update Posted: | July 2, 2017 |
Last Verified: | June 2017 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
commercial heart monitors accuracy EKG varying degrees of exertion |